Analysts Issue Forecasts for PLRX FY2026 Earnings
Pliant Therapeutics, Inc. (NASDAQ:PLRX – Free Report) – Equities researchers at Cantor Fitzgerald issued their FY2026 earnings estimates for Pliant Therapeutics in a research note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst P. Stavropoulos anticipates that the company will earn ($1.34) per share for the year. Cantor Fitzgerald currently has a “Neutral” […]
